AI tool predicts cancer treatment outcomes with high accuracy

Researchers at Harvard Medical School have developed an AI model named CHIEF, achieving nearly 94% accuracy in cancer detection across 19 types. Trained on 15 million images, it predicts patient survival and tumor responses to treatments, outperforming existing AI systems by up to 36%. CHIEF's capabilities include identifying genetic mutations and tumor characteristics, enhancing cancer diagnosis and treatment personalization globally.